United States · Health Care · USD (Thousands) · Annual
Reported figures and Equlion model projections for the next 5 years.
Sector average (own scale)
Sector average
Sector average (own scale)
Amounts in USD (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for GeneDx Holdings Corp.? It covers the balance sheet, income statement, cash flow and Equlion model projections.
| Key metrics | Actual | Forecast | ||||
|---|---|---|---|---|---|---|
| Metric | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
| ROE | -7.6% | -8.59% | -17.56% | -36.2% | -97.78% | 826.34% |
| Sector average | 22.99% | 73.17% | 65.88% | 68.36% | 41.61% | 44.34% |
| ROA | -4.46% | -4.85% | -8.63% | -12.56% | -16.21% | -20.32% |
| Gross Margin | 69.74% | 69.36% | 66.27% | 63.17% | 59.65% | 56.1% |
| Sector average | 45.84% | 46.72% | 46.7% | |||
| Net Margin | -4.92% | -5.3% | -8.37% | -11.43% | -14.91% | -19.29% |
| Total Assets | $523,710.00K | $524,022.39K | $534,166.52K | $623,113.81K | $709,363.08K | $756,456.99K |
| Sector average | $3,516,665.42K | $3,537,396.33K | $3,954,880.66K | |||
| Net Income | -$21,021.00K | -$25,381.47K | -$45,653.73K | -$72,695.06K | -$107,998.30K | -$148,959.83K |
| 45.37% |
| 44.33% |
| 43.24% |
| $4,602,556.36K |
| $5,424,035.31K |
| $6,260,073.84K |